User: Guest  Login
Title:

Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention

Document type:
Article
Author(s):
Busch, G; Steppich, B; Sibbing, D; Braun, SL; Stein, A; Groha, P; Schoemig, A; Kastrati, A; von Beckerath, N; Ott, I
Abstract:
Concomitant antithrombotic therapy is essential for the prevention of ischaemic events in percutaneous coronary intervention (PCI) and stenting. With new anticoagulant medications being developed and applied in PCI, this raises the question of possible interactions with platelet and leukocyte activation. We therefore sought to investigate the influence of bivalirudin and heparin in platelet and leukocyte activation in patients undergoing elective PCI. Forty-six patients were recruited consecutiv...     »
Journal title abbreviation:
J Thromb Haemost
Year:
2009
Journal volume:
101
Journal issue:
2
Pages contribution:
340-344
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/19190819
Print-ISSN:
1538-7933
TUM Institution:
I. Medizinische Klinik und Poliklinik (Kardiologie); Institut für Laboratoriumsmedizin (keine SAP-Zuordnung!)
 BibTeX